Alternative Methods in Science: Towards Fluidic Systems
Main Article Content
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles are distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is appropriately cited (CC-BY). Copyright on any article in ALTEX is retained by the author(s).
Chary, A., Groff, K., Stuck, A. O. et al. (2022). Maximizing the relevance and reproducibility of A549 cell culture using FBS-free media. Toxicol In Vitro 83, 105423. doi:10.1016/j.tiv.2022.105423
Dalsbecker, P., Beck Adiels, C. and Goksör, M. (2022). Liver-on-a-chip devices: The pros and cons of complexity. Am J Physiol Gastrointest Liver Physiol 323, G188-G204. doi:10.1152/ajpgi.00346.2021
Gough, A., Soto-Gutierrez, A., Vernetti, L. et al. (2021). Human biomimetic liver microphysiology systems in drug development and precision medicine. Nat Rev Gastroenterol Hepatol 18, 252-268. doi:10.1038/s41575-020-00386-1
Lauschke, V. M., Vorrink, S. U., Moro, S. M. L. et al. (2016). Massive rearrangements of cellular MicroRNA signatures are key drivers of hepatocyte dedifferentiation. Hepatology 64, 1743-1756. doi:10.1002/hep.28780
Lauschke, V. M., Milani, L. and Ingelman-Sundberg, M. (2017). Pharmacogenomic biomarkers for improved drug therapy-recent progress and future developments. AAPS J 20, 4. doi:10.1208/s12248-017-0161-x
O’Brien, P. J., Irwin, W., Diaz, D. et al. (2006). High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch Toxicol 80, 580-604. doi:10.1007/s00204-006-0091-3
Sirenko, O., Hesley, J., Rusyn, I. et al. (2014). High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells. Assay Drug Dev Technol 12, 43-54. doi:10.1089/adt.2013.520
Tolosa, L., Pinto, S., Donato, M. T. et al. (2012). Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs. Toxicol Sci 127, 187-198. doi:10.1093/toxsci/kfs083
von Aulock, S., Busquet, F., Locke, P. et al. (2022). Engagement of scientists with the public and policymakers to promote alternative methods. ALTEX 39, 543-559. doi:10.14573/altex.2209261
Waring, M. J., Arrowsmith, J., Leach, A. R. et al. (2015). An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nat Rev Drug Discov 14, 475-486. doi:10.1038/nrd4609
Zhao, P., Wang, J., Chen, C. et al. (2022). Microfluidic applications in drug development: Fabrication of drug carriers and drug toxicity screening. Micromachines 13, 200. doi:10.3390/mi13020200